Researchers have shown, in mice, that a new class of compounds they developed can improve several aspects of metabolic syndrome. Such conditions often lead to cardiovascular disease, the leading cause of death worldwide.
Diabetes, metabolic syndrome in mice treated with novel class of compounds
